BookR: School of Health Core Facilities Booking
PubMed Publications| Keyword search (4,163 papers available) |  |
"Neuroimaging" Keyword-tagged Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Hierarchical Storage Management in User Space for Neuroimaging Applications | Hayot-Sasson V; Glatard T; | 41432812 ENCS |
| 2 | Patterns of Structural Disconnection Driving Proprioceptive Deficits in Chronic Stroke | Kaeja M; Gajiyeva L; Iturria-Medina Y; Villringer A; Sehm B; Steele C; | 41392885 SOH |
| 3 | The PREVENT-AD cohort: Accelerating Alzheimer s disease research and treatment in Canada and beyond | Villeneuve S; Poirier J; Breitner JCS; Tremblay-Mercier J; Remz J; Raoult JM; Yakoub Y; Gallego-Rudolf J; Qiu T; Fajardo Valdez A; Mohammediyan B; Javanray M; Metz A; Sanami S; Ourry V; Wearn A; Pastor-Bernier A; Edde M; Gonneaud J; Strikwerda-Brown C; Tardif CL; Gauthier CJ; Descoteaux M; Dadar M; Vachon-Presseau É; Baril AA; Ducharme S; Montembeault M; Geddes MR; Soucy JP; Rajah N; Laforce R; Bocti C; Davatzikos C; Bellec L; Rosa-Neto P; Baillet S; Evans AC; Collins DL; Chakravarty MM; Blennow K; Zetterbe | 41020412 SOH |
| 4 | The PREVENT-AD cohort: accelerating Alzheimer s disease research and treatment in Canada and beyond | Villeneuve S; Poirier J; Breitner JCS; Tremblay-Mercier J; Remz J; Raoult JM; Yakoub Y; Gallego-Rudolf J; Qiu T; Valdez AF; Mohammediyan B; Javanray M; Metz A; Sanami S; Ourry V; Wearn A; Pastor-Bernier A; Edde M; Gonneaud J; Strikwerda-Brown C; Tardif CL; Gauthier CJ; Descoteaux M; Dadar M; Vachon-Presseau É; Baril AA; Ducharme S; Montembeault M; Geddes MR; Soucy JP; Rajah N; Laforce R; Bocti C; Davatzikos C; Bellec L; Rosa-Neto P; Baillet S; Evans AC; Collins DL; Chakravarty MM; Blennow K; Zetterberg H; S | 40778177 PSYCHOLOGY |
| 5 | Open-source platforms to investigate analytical flexibility in neuroimaging | Sanz-Robinson J; Wang M; McPherson B; Chatelain Y; Kennedy D; Glatard T; Poline JB; | 40800896 ENCS |
| 6 | Detrimental Effects of Space Flight on the Lumbar Spine May Be Correlated to Baseline Degeneration: Insights From an Advanced MR Imaging Study | Bokhari R; Bisson DG; Fortin M; Vigouroux M; Cata JP; Hwang KP; Chen MM; Ceniza-Bordallo G; Ouellet JA; Ingelmo PM; | 40124538 HKAP |
| 7 | An analysis of performance bottlenecks in MRI preprocessing | Dugré M; Chatelain Y; Glatard T; | 40072903 ENCS |
| 8 | Sleep neuroimaging: Review and future directions | Pereira M; Chen X; Paltarzhytskaya A; Pache?o Y; Muller N; Bovy L; Lei X; Chen W; Ren H; Song C; Lewis LD; Dang-Vu TT; Czisch M; Picchioni D; Duyn J; Peigneux P; Tagliazucchi E; Dresler M; | 39940102 HKAP |
| 9 | Using evolutionary theory to enhance the brain imaging paradigm | Saad G; Greengross G; | 24999326 JMSB |
| 10 | Fractals in Neuroimaging | Lahmiri S; Boukadoum M; Di Ieva A; | 38468046 JMSB |
| 11 | At-home computerized executive-function training to improve cognition and mobility in normal-hearing adults and older hearing aid users: a multi-centre, single-blinded randomized controlled trial | Downey R; Gagné N; Mohanathas N; Campos JL; Pichora-Fuller KM; Bherer L; Lussier M; Phillips NA; Wittich W; St-Onge N; Gagné JP; Li K; | 37864139 PERFORM |
| 12 | Web-based processing of physiological noise in fMRI: addition of the PhysIO toolbox to CBRAIN | Valevicius D; Beck N; Kasper L; Boroday S; Bayer J; Rioux P; Caron B; Adalat R; Evans AC; Khalili-Mahani N; | 37841811 ENCS |
| 13 | Electroencephalographic characteristics of children and adolescents with chronic musculoskeletal pain | Ocay DD; Teel EF; Luo OD; Savignac C; Mahdid Y; Blain-Moraes S; Ferland CE; | 36601627 HKAP |
| 14 | Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies | Percie du Sert O; Unrau J; Gauthier CJ; Chakravarty M; Malla A; Lepage M; Raucher-Chéné D; | 36341843 CRDH |
| 15 | The BigBrainWarp toolbox for integration of BigBrain 3D histology with multimodal neuroimaging | Paquola C; Royer J; Lewis LB; Lepage C; Glatard T; Wagstyl K; DeKraker J; Toussaint PJ; Valk SL; Collins DL; Khan A; Amunts K; Evans AC; Dickscheid T; Bernhardt BC; | 34431476 IMAGING |
| 16 | A Simulation Toolkit for Testing the Sensitivity and Accuracy of Corticometry Pipelines | OmidYeganeh M; Khalili-Mahani N; Bermudez P; Ross A; Lepage C; Vincent RD; Jeon S; Lewis LB; Das S; Zijdenbos AP; Rioux P; Adalat R; Van Eede MC; Evans AC; | 34381348 PERFORM |
| 17 | Comparing the effect of Cognitive vs. Exercise Training on brain MRI outcomes in healthy older adults: A systematic review | Intzandt B; Vrinceanu T; Huck J; Vincent T; Montero-Odasso M; Gauthier CJ; Bherer L; | 34245760 PERFORM |
| 18 | An analysis of security vulnerabilities in container images for scientific data analysis | Kaur B; Dugré M; Hanna A; Glatard T; | 34080631 ENCS |
| 19 | File-based localization of numerical perturbations in data analysis pipelines. | Salari A, Kiar G, Lewis L, Evans AC, Glatard T | 33269388 ENCS |
| 20 | Comparing perturbation models for evaluating stability of neuroimaging pipelines. | Kiar G, de Oliveira Castro P, Rioux P, Petit E, Brown ST, Evans AC, Glatard T | 32831546 IMAGING |
| 21 | Novel FMRI-Compatible wrist robotic device for brain activation assessment during rehabilitation exercise | H Sharini, N Riyahi Alam, H Khabiri, H Arabalibeik, H Hashemi, A R Azimi, S Masjoodi | 32507416 PERFORM |
| 22 | The Neuroscience of Sadness: A Multidisciplinary Synthesis and Collaborative Review for the Human Affectome Project. | Arias JA, Williams C, Raghvani R, Aghajani M, Baez S, Belzung C, Booij L, Busatto G, Chiarella J, Fu CH, Ibanez A, Liddell BJ, Lowe L, Penninx BWJH, Rosa P, Kemp AH | 32001274 PSYCHOLOGY |
| 23 | Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment | Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; Belleville S; | 31758692 CRDH |
| 24 | Beyond sleepy: structural and functional changes of the default-mode network in idiopathic hypersomnia. | Pomares FB, Boucetta S, Lachapelle F, Steffener J, Montplaisir J, Cha J, Kim H, Dang-Vu TT | 31328786 PERFORM |
| 25 | Cyberinfrastructure for Open Science at the Montreal Neurological Institute. | Das S, Glatard T, Rogers C, Saigle J, Paiva S, MacIntyre L, Safi-Harab M, Rousseau ME, Stirling J, Khalili-Mahani N, MacFarlane D, Kostopoulos P, Rioux P, Madjar C, Lecours-Boucher X, Vanamala S, Adalat R, Mohaddes Z, Fonov VS, Milot S, Leppert I, Degroot C, Durcan TM, Campbell T, Moreau J, Dagher A, Collins DL, Karamchandani J, Bar-Or A, Fon EA, Hoge R, Baillet S, Rouleau G, Evans AC | 28111547 IMAGING |
| 26 | Cortical Thinning and Altered Cortico-Cortical Structural Covariance of the Default Mode Network in Patients with Persistent Insomnia Symptoms. | Suh S, Kim H, Dang-Vu TT, Joo E, Shin C | 26414892 PERFORM |
| 27 | Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry. | Khalili-Mahani N, Rombouts SA, van Osch MJ, Duff EP, Carbonell F, Nickerson LD, Becerra L, Dahan A, Evans AC, Soucy JP, Wise R, Zijdenbos AP, van Gerven JM | 28145075 PERFORM |
| Title: | The PREVENT-AD cohort: Accelerating Alzheimer s disease research and treatment in Canada and beyond | ||||
| Authors: | Villeneuve S, Poirier J, Breitner JCS, Tremblay-Mercier J, Remz J, Raoult JM, Yakoub Y, Gallego-Rudolf J, Qiu T, Fajardo Valdez A, Mohammediyan B, Javanray M, Metz A, Sanami S, Ourry V, Wearn A, Pastor-Bernier A, Edde M, Gonneaud J, Strikwerda-Brown C, Tardif CL, Gauthier CJ, Descoteaux M, Dadar M, Vachon-Presseau É, Baril AA, Ducharme S, Montembeault M, Geddes MR, Soucy JP, Rajah N, Laforce R, Bocti C, Davatzikos C, Bellec L, Rosa-Neto P, Baillet S, Evans AC, Collins DL, Chakravarty MM, Blennow K, Zetterbe | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/41020412/ | ||||
| DOI: | 10.1002/alz.70653 | ||||
| Publication: | Alzheimer s & dementia : the journal of the Alzheimer s Association | ||||
| Keywords: | biomarkers; clinical progression; cognition; data repository; neuroimaging; preclinical; | ||||
| PMID: | 41020412 | Category: | Date Added: | 2025-09-29 | |
| Dept Affiliation: |
SOH
1 StoP-AD Centre, Douglas Mental Health University Institute, McGill University, Montréal, Quebec, Canada. 2 Department of Psychiatry, McGill University, Montréal, Quebec, Canada. 3 McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada. 4 Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University, Montréal, Quebec, Canada. 5 Integrated Program in Neuroscience, McGill University, Montréal, Quebec, Canada. 6 Research Center of the CIUSSS-NIM, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. 7 Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada. 8 Department of Physics, Concordia University, Montréal, Quebec, Canada. 9 Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada. 10 Faculté des sciences, Département d'informatique, Université de Sherbrooke, Sherbrooke, Quebec, Canada. 11 Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", NeuroPresage Team, GIP Cyceron, Caen, France. 12 School of Psychological Science, The University of Western Australia, Perth, Western Australia, Australia. 13 Department Biomedical Engineering, McGill University, Montréal, Quebec, Canada. 14 Centre ÉPIC, Montreal Heart Institute, Montréal, Quebec, Canada. 15 School of Health, Concordia University, Montréal, Quebec, Canada. 16 Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada. 17 Department of Anesthesia, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada. 18 Alan Edwards Center for Research on Pain, McGill University, Montreal, Quebec, Canada. 19 Department of Psychology, Toronto Metropolitan University, Toronto, Ontario, Canada. 20 Clinique interdisciplinaire de mémoire, CHU de Québec affilié à l'Université Laval, Québec, Quebec, Canada. 21 Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada. 22 AI2D Center for AI and Data Science for Integrated Diagnostics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 23 Psychology Department, Université de Montréal, Montréal, Quebec, Canada. 24 Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, Quebec, Canada. 25 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. 26 Clinical Neurochemistry Lab, Sahlgrenska University Hospital, Mölndal, Sweden. 27 Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France. 28 Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, Anhui, P.R. China. 29 Department of Neurodegenerative Disease, University College London Institute of Neurology, London, UK. 30 UK Dementia Research Institute at UCL, London, UK. 31 Hong Kong Center for Neurodegenerative Diseases, InnoHK, Hong Kong, China. 32 Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA. 33 Department of Physiology and Pharmacology, Université de Montréal, Montréal, Quebec, Canada. 34 Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. |
||||
Description: |
The PResymptomatic EValuation of Experimental or Novel Treatments for Alzheimer's Disease (PREVENT-AD) is an investigator-driven study that was created in 2011 and enrolled cognitively normal older adults with a family history of sporadic AD. Participants are deeply phenotyped and have now been followed annually for more than 12 years (median follow-up 8.0 years, SD 3.1). Multimodal magnetic resonance imaging (MRI), genetic, neurosensory, clinical, cerebrospinal fluid, and cognitive data collected until 2017 on 348 participants who agreed to open sharing with the neuroscience community were already available. We now share a new release including 6 years of additional follow-up cognitive data, and additional MRI follow-ups, clinical progression, new longitudinal behavioral and lifestyle measures (questionnaires, actigraphy), longitudinal AD plasma biomarkers, amyloid-beta and tau positron emission tomography (PET), magnetoencephalography, as well as neuroimaging analytic measures from all MRI modalities. We describe the PREVENT-AD study, the data shared with the global research community, as well as the model we created to sustain longitudinal follow-ups while also allowing new innovative data collection. HIGHLIGHTS: The PResymptomatic EValuation of Experimental or Novel Treatments for Alzheimer's Disease (PREVENT-AD) is a single-site longitudinal study that started in 2011 with annual follow-up data collection on individuals at risk of Alzheimer's disease who were all cognitively normal at enrolment. All 387 participants were enrolled between 2011 and 2017 and 306 (79%) of these participants were still in the study as of December 2023. While the PREVENT-AD dataset was not originally planned to be shared with the global research community, 348 participants retrospectively consented for their data to be shared with researchers worldwide. The first release of data was in 2019. We now share a second release that includes 6 years of additional follow-up visits, information on clinical progression and novel cognitive, behavioral, genetic, plasma and neuroimaging (amyloid and tau positron emission tomography [PET], magnetoencephalography [MEG], and new magnetic resonance imaging [MRI] sequences) data. It also includes analytic outputs for neuroimaging modalities. |
